| Bioactivity | SARS-CoV-2 Mpro-IN-25 (Compound 3a) is a SARS-CoV-2 protease inhibitor with an IC50 value of 0.26 μM. SARS-CoV-2 Mpro-IN-25 exhibits antiviral activity and can be used in pneumonia-related research[1]. |
| CAS | 2205006-23-9 |
| Formula | C13H10FNO4 |
| Molar Mass | 263.22 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. de Carvalho MAG, et al. Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS-CoV-2 main protease. Arch Pharm (Weinheim). 2024 Aug 15:e2400253. |
SARS-CoV-2 Mpro-IN-25
CAS: 2205006-23-9 F: C13H10FNO4 W: 263.22
SARS-CoV-2 Mpro-IN-25 (Compound 3a) is a SARS-CoV-2 protease inhibitor with an IC50 value of 0.26 μM. SARS-CoV-2 Mpro-I
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.